The Nevada Department of Health and Human Services (DHHS) recently released draft procedures related to pharmaceutical representative registration in response to Nevada SB 539. An overview of Nevada SB 539, which provides sweeping transparency legislation related to several aspects of the pharmaceutical industry, is available here.
The draft procedures require registration by pharmaceutical representatives that physically visit Nevada for 5 or more days annually to:
-
communicate with health care providers;
-
engage in the marketing of prescription drugs to doctors or other health care providers, pharmacists or pharmacy employees, and employees of medical facilities;
-
meet with physicians or other healthcare providers to answer questions about product use and benefits or provide discussion and product information and resources to key decision makers while representing the manufacturer or supporting promotional efforts of the manufacturer; or
-
distribute FDA regulated product samples and product information.
Registration is not required for attending a trade conference or convention hosted in Nevada that is not solely marketed to health care providers licensed in Nevada; activities related to clinical trials, investigational drugs, or Risk Evaluation and Mitigation Strategies (REMS); and activities performed by wholesale distributors who do not represent a single manufacturer.
Pharmaceutical representatives must register with DHHS by October 1st or within 30 days after hire, and must be registered before engaging in work in Nevada. The employing manufacturer may send an email to drugtransparency@dhhs.nv.gov to add or remove names from the registry.
[View source.]
